News

Syndax Announces FDA Priority Review Of NDA For Revumenib For Treatment Of R/R KMT2Ar Acute Leukemia

Syndax Pharmaceuticals has announced that its New Drug Application (NDA) for revumenib has been granted Priority Review by the U.S. Food and Drug Admi ...more

Australian Market Modestly Higher

The Australian stock market is performing slightly stronger on Wednesday, rebounding from previous loss-making sessions. The key S&P/ASX 200 slipped s ...more

Hong Kong Stock Market Tipped To Open In The Red

The Hong Kong stock market broke a two-day losing streak on Tuesday, which saw a nearly 400-point, or 2.5 percent, drop. The Hang Seng Index is curren ...more

Soft Start Predicted For China Stock Market

On Tuesday, the Chinese stock market turned around a three-day downward trend during which it had declined by over 50 points or 1.7%. The Shanghai Com ...more

Tech Shares May Drag Taiwan Stock Market Lower On Wednesday

The Taiwan equity market has experienced consecutive losses for two sessions, plummeting over 100 points or falling by 0.5%. The Taiwan Stock Exchange ...more

Chinese Industrial Profits Soar by 12.5% YTD in February 2024

Chinese industrial profits have seen a significant turnaround in February 2024, with a sharp increase of 12.5% year-to-date. This positive change come ...more

Forecasts

USDCHF Wave Analysis

USDCHF broke the resistance level 0.8875 Likely to rise to resistance level 0.9100 USDCHF currency pair recently broke the resistance level 0.8875 (w ...more

EUR/USD Mid-Day Outlook

Daily Pivots: (S1) 1.0812; (P) 1.0827; (R1) 1.0852; More… Intraday bias in EUR/USD stays neutral for the moment, with consolidations from 1.080 ...more

GBP/USD Mid-Day Outlook

Daily Pivots: (S1) 1.2602; (P) 1.2627; (R1) 1.2663; More… Intraday bias in GBP/USD stays neutral, as consolidations from 1.2574 continues. Risk ...more

USD/JPY Mid-Day Outlook

Daily Pivots: (S1) 151.13; (P) 151.35; (R1) 151.64; More… Outlook in USD/JPY remains unchanged at consolidation from 151.82 is still extending. ...more

USD/CHF Mid-Day Outlook

Daily Pivots: (S1) 0.8977; (P) 0.8986; (R1) 0.9004; More…. USD/CHF’s rally resumed after brief consolidations and intraday bias is back o ...more

EUR/USD Daily Outlook

Daily Pivots: (S1) 1.0812; (P) 1.0827; (R1) 1.0852; More… Intraday bias in EUR/USD remains neutral for consolidation s above 1.0801 temporary l ...more

Technical Analysis

AUDUSD Technical Analysis

USDThe Fed left interest rates unchanged as expected with basically no change to the statement. The Dot Plot still showed three rate cuts for 2024 and ...more

USDCAD Technical Analysis - Key support zone in sight

USDThe Fed left interest rates unchanged as expected with basically no change to the statement. The Dot Plot still showed three rate cuts for 2024 and ...more

EURUSD Technical Analysis

USDThe Fed left interest rates unchanged as expected with basically no change to the statement. The Dot Plot still showed three rate cuts for 2024 and ...more

Nasdaq Composite Technical Analysis

Yesterday, the Nasdaq Composite managed to close the day positive although the price continues to retreat towards the key support zone around the 1620 ...more

USDJPY Technical Analysis

USDThe Fed left interest rates unchanged as expected with basically no change to the statement. The Dot Plot still showed three rate cuts for 2024 and ...more

GBPUSD Technical Analysis - Key levels to watch out for

USDThe Fed left interest rates unchanged as expected with basically no change to the statement. The Dot Plot still showed three rate cuts for 2024 and ...more

Charts

Suggested Brokers

Type: Forex
Min. Deposit: $20
US Traders: No
Regulated: Yes
Type: Binary Option
Min. Deposit: $10
US Traders: No
Regulated: Yes
Type: Forex
Min. Deposit: $50
US Traders: No
Regulated: Yes
Type: Forex
Min. Deposit: $5
US Traders: No
Regulated: Yes
Type: Forex
Min. Deposit: $1000
US Traders: No
Regulated: Yes

Our Partners